The results showed that VDR Bsm I gene polymorphism played an important role in estimating LVH risk of MDH patients, and provided theoretical basis for early detection and active prevention of cardiovascular complications and improvement of prognosis of patients with end-stage renal disease. The gene discussed is VDR; the disease is chronic kidney disease.